These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4258288)

  • 1. Metabolic alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide and prevented by nicotinamide.
    Ofori-Nkansah N; von Bruchhausen F
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(2):156-68. PubMed ID: 4258288
    [No Abstract]   [Full Text] [Related]  

  • 2. Some metabolic and morphological alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide.
    Ofori-Nkansah N; von Bruchhausen F
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 77(1):64-76. PubMed ID: 4259986
    [No Abstract]   [Full Text] [Related]  

  • 3. [The impairment of glycogen metabolism in adipose tissue by 6-aminonicotinamide as influenced by the inhibition of phosphofructokinase].
    Ofori-Nkansah N; von Bruchhausen F
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(2):143-55. PubMed ID: 4258287
    [No Abstract]   [Full Text] [Related]  

  • 4. Transformation of glucosamine to glycogen and lactate by ascites tumor cells.
    Sukeno T; Kikuchi H; Saeki H; Tsuiki S
    Biochim Biophys Acta; 1971 Jul; 244(1):19-29. PubMed ID: 4330425
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral energy reserves and glycolysis in neural tissue of 6-aminonicotinamide-treated mice.
    Kauffman FC; Johnson EC
    J Neurobiol; 1974; 5(5):379-92. PubMed ID: 4156048
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of chlorambucil treatment on the rates of respiration and glycolysis in drug-sensitive and -resistant strains of the Yoshida ascites sarcoma.
    Hill BT; Riches PG; Furness ME
    Biochem Pharmacol; 1970 Dec; 19(12):2973-8. PubMed ID: 5534949
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic alterations in the axotomized superior cervical ganglion of the rat. I. Energy metabolism.
    Härkönen MH; Kauffman FC
    Brain Res; 1974 Jan; 65(1):127-39. PubMed ID: 4149251
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro-in vivo studies on the susceptibility of the solid Yoshida sarcoma to drugs and hyperthermia (42 degrees).
    Dickson JA; Suzangar M
    Cancer Res; 1974 Jun; 34(6):1263-74. PubMed ID: 4363651
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyrimidine metabolism in normal and tumor tissues.
    Imura H; Okuda H; Takeda K; Fujii S
    Gan; 1972 Dec; 63(6):685-92. PubMed ID: 4648070
    [No Abstract]   [Full Text] [Related]  

  • 10. Some effects of chlorambucil on the chromatin of Yoshida ascites sarcoma cells.
    Riches PG; Harrap KR
    Cancer Res; 1973 Feb; 33(2):389-93. PubMed ID: 4688885
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of oxamate, pyruvate, nicotinamide and streptozotocin on the pentose phosphate pathway intermediates in ascites tumour cells.
    Gumaa KA; McLean P
    Biochem Biophys Res Commun; 1969 Apr; 35(1):86-93. PubMed ID: 4388549
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyridine nucleotide analog interference with metabolic processes in mitogen-stimulated human T lymphocytes.
    Berger SJ; Manory I; Sudar DC; Krothapalli D; Berger NA
    Exp Cell Res; 1987 Dec; 173(2):379-87. PubMed ID: 2961586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of cancer cells radiosensitivity. II. Influence of the crabtree effect on radiosensitivity of Yoshida ascites sarcoma cells.
    Watras J; Widel M
    Radiobiol Radiother (Berl); 1973; 14(1):73-8. PubMed ID: 4689210
    [No Abstract]   [Full Text] [Related]  

  • 14. INHIBITION OF AMINO ACID INCORPORATION INTO PROTEIN OF YOSHIDA ASCITES HEPATOMA CELLS BY GLYCERALDEHYDE.
    GUIDOTTI GG; FONNESU A; CIARANFI E
    Cancer Res; 1964 Jun; 24():900-5. PubMed ID: 14190555
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of correlation between the carcinostatic effect and the inhibition of glycolysis caused by tris-(beta-chlorethyl)-amine.
    Svec J; Sauermann G
    Chemotherapy; 1970; 15(1):12-8. PubMed ID: 4245149
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of carbohydrate metabolism in rat kidney after pharmacological blockade of the pentose phosphate pathway.
    Kolbe H; Keller K; Lange K; Herken H
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(1):93-102. PubMed ID: 4256398
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 3-deoxy-3-fluoro-D-glucose on glycolytic intermediates and adenine nucleotides in resting cells of Saccharomyces cerevisiae.
    Woodward B; Taylor NF; Brunt RV
    Biochem Pharmacol; 1971 Jun; 20(6):1071-7. PubMed ID: 5118110
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic consequences of drug-induced inhibition of the pentose phosphate pathway in neuroblastoma and glioma cells.
    Kolbe H; Keller K; Lange K; Herken H
    Biochem Biophys Res Commun; 1976 Nov; 73(2):378-82. PubMed ID: 136966
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of glucokinase in Methanomonas sp. as a cause for their inability to grow on glucose.
    Amemiya K
    Can J Microbiol; 1972 Dec; 18(12):1907-13. PubMed ID: 4567975
    [No Abstract]   [Full Text] [Related]  

  • 20. The dissimilation of glucose and gluconate by Acetobacter xylinum. 1. The origin and the fate of triose phosphate.
    White GA; Wang CH
    Biochem J; 1964 Feb; 90(2):408-23. PubMed ID: 4220768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.